AAAAAA
Results: 26-37/37
Authors:
Rudat, V
Dietz, A
Schramm, O
Conradt, C
Maier, H
Flentje, M
Wannenmacher, M
Citation: V. Rudat et al., Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy, RADIOTH ONC, 53(2), 1999, pp. 119-125
Authors:
Sommer, O
Dietz, A
Westermann, R
Ertl, T
Citation: O. Sommer et al., An interactive visualization and navigation tool for medical volume data, COMPUT GRAP, 23(2), 1999, pp. 233-244
Authors:
Baudis, L
Dietz, A
Heusser, G
Klapdor-Kleingrothaus, HV
Krivosheina, IV
Kolb, S
Majorovits, B
Melnikov, VF
Pas, H
Schwamm, F
Strecker, H
Alexeev, V
Balysh, A
Bakalyarov, A
Belyaev, ST
Lebedev, VI
Zhukov, S
Citation: L. Baudis et al., Limits on the Majorana neutrino mass in the 0.1 eV range, PHYS REV L, 83(1), 1999, pp. 41-44
Authors:
Haas, S
Bosch, FX
Klein-Kuhne, W
Nollert, J
Rudat, V
Conradt, C
Dietz, A
Citation: S. Haas et al., Prognostic significance of cell-cycle regulatory proteins for outcome after primary radiochemotherapy in patients with advanced head and neck cancer, HNO, 47(9), 1999, pp. 777
Authors:
Helbig, M
Andl, T
Kahn, T
Klein-Kuhne, W
Conradt, C
Dietz, A
Bosch, FX
Citation: M. Helbig et al., The role of oncogenic human papillomaviruses in tonsillar squamous cell carcinomas with functional inactivation of the retinoblastoma protein, HNO, 47(9), 1999, pp. 796-803
Authors:
Bosch, FX
Homann, N
Conradt, C
Dietz, A
Erber, R
Citation: Fx. Bosch et al., p53 mutations/p53 protein overexpression. Differential significance for the progression of head-neck carcinomas, HNO, 47(9), 1999, pp. 833-848
Authors:
Dietz, A
Rudat, V
Vanselow, B
Conradt, C
Mohler, T
Citation: A. Dietz et al., Predictive value of serum levels of basic fibroblast growth factor, vascular endothelial growth factor and matrix metalloproteinase-2 in advanced carcinomas of the head and neck, HNO, 47(8), 1999, pp. 695-701
Authors:
Maier, H
Tisch, M
Dietz, A
Conradt, C
Citation: H. Maier et al., Construction workers as an extreme risk group for head and neck cancer, HNO, 47(8), 1999, pp. 730-736
Authors:
Nollert, J
Rudat, V
Daniel, V
Maier, H
Dietz, A
Citation: J. Nollert et al., Immunomodulating effects of chemoradiation therapy in patients suffering from tumors in head and neck, HNO, 47(12), 1999, pp. 1058-1062
Authors:
Heimlich, F
Dietz, A
Daniel, V
Maier, H
Citation: F. Heimlich et al., Immunosuppression caused by head and neck surgery, HNO, 47(10), 1999, pp. 885-892
Authors:
Schlemmer, HP
Becker, M
Bachert, P
Dietz, A
Rudat, V
Vanselow, B
Wollensack, P
Zuna, I
Knopp, MV
Weidauer, H
Wannenmacher, F
van Kaick, G
Citation: Hp. Schlemmer et al., Alterations of intratumoral pharmacokinetics of 5-fluorouracil in head andneck carcinoma during simultaneous radiochemotherapy, CANCER RES, 59(10), 1999, pp. 2363-2369
Authors:
Bier, H
Bonkowsky, V
Dietz, A
Schrader, M
Tolsdorf, P
Iro, H
Citation: H. Bier et al., Oncological consulting hour, LARY RH OTO, 77(11), 1998, pp. 635-635